• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up0.65%

    Vanda Pharmaceuticals, Inc. (VNDA)

    -NasdaqGM
    10.61 Up 1.12(11.80%) 4:00PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue 109,925   50,157   33,879  
    Cost of Revenue23,462  1,583   -  
    Gross Profit 86,463   48,574   33,879  
    Operating Expenses
    Research Development29,145  19,230  28,502  
    Selling General and Administrative84,531  84,644  25,082  
    Non Recurring -   -   -  
    Others12,972  2,254  1,495  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (40,185) 20,062   (21,200)
    Income from Continuing Operations
    Total Other Income/Expenses Net320  77,740  145  
    Earnings Before Interest And Taxes(39,865)97,802  (21,055)
    Interest Expense -   -   -  
    Income Before Tax(39,865)97,802  (21,055)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(39,865)97,802  (21,055)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (39,865) 20,186   (21,055)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (39,865) 20,186   (21,055)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.